![](/img/cover-not-exists.png)
Identifying susceptibilities and pharmacodynamic biomarkers for mirvetuximab soravtansine in high-grade ovarian and endometrial cancer
Hopp, E., Joseph, P., Nakayama, J., Zanotti, K.M., Nagel, C.I., Waggoner, S.E., DiFeo, A.Volume:
149
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2018.04.126
Date:
June, 2018
File:
PDF, 52 KB
english, 2018